-+ 0.00%
-+ 0.00%
-+ 0.00%

Immix Biopharma prices 11,363,637-share offering at USD 11.00 per share for USD 125 million gross proceeds

PUBT·09/29/2026 11:05:20
Listen to the news
Immix Biopharma prices 11,363,637-share offering at USD 11.00 per share for USD 125 million gross proceeds
  • Immix Biopharma priced an underwritten offering of 11,363,637 common shares at USD 11.00 each.
  • Gross proceeds expected at USD 125 million before underwriting discounts, commissions, and offering expenses.
  • Closing expected on or about Sept. 30, 2026, subject to customary conditions.
  • Net proceeds earmarked for NXC-201 development, working capital, and general corporate purposes.
  • J.P. Morgan is sole book-running manager.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290705PRIMZONEFULLFEED9835887) on September 29, 2026, and is solely responsible for the information contained therein.